MRSA Costs Savings from Adopting RP 2.1 + TEST (£)

A 5.5 KB Excel file authored by Raymond Oppong and last updated in April 2026. This dataset likely contains financial estimates for cost savings associated with adopting a specific protocol for Methicillin-resistant Staphylococcus aureus (MRSA). The data is licensed for open use under CC-BY-4.0.

Use Cases

• Modeling the economic impact of MRSA prevention protocols based on the described cost savings.
• Conducting cost-benefit analyses for healthcare interventions based on the financial estimates.
• Benchmarking hospital savings from infection control measures based on the provided monetary figures.

Strengths

• File size is precisely 5.5 KB, indicating a compact and focused dataset.
• Has a clear open license (CC-BY-4.0) permitting reuse and modification.
• Last update date is explicitly recorded as 2026-04 27 17:26:54.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Raymond Oppong via figshare.

Collection Method

Method of data gathering is not described.

Time Range

Temporal coverage is not specified.

Freshness

Last updated 2026-04-27 17:26:54; freshness should be verified.

Geography

Spatial coverage is not specified; monetary unit (£) suggests a UK context.